微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
Cediranib (AZD2171)是一种高效的VEGFR(KDR)抑制剂，此外对c-Kit和PDGFRβ也具有相似的抑制活性，对VEGFR的选择性比PDGFR-α，CSF-1R和Flt3分别高36倍，110倍 和1000倍以上。
Targets
| Target | Value |
|---|---|
| VEGFR2/KDR | IC50: 0.5nM |
| c-Kit | IC50: 2nM |
| VEGFR3/FLT4 | IC50: <=3nM |
| VEGFR1/FLT1 | IC50: 5nM |
| PDGFRβ | IC50: 5nM |
| FGFR1 | IC50: 26nM |
| PDGFRα | IC50: 36nM |
| CSF-1R | IC50: 110nM |
| Src | IC50: 130nM |
| Abl | IC50: 260nM |
| FLT3 | IC50: >1μM |
| HER2/ErbB2 | IC50: >1μM |
| CDK2 | IC50: >1μM |
| CDK4 | IC50: >1μM |
| EGFR | IC50: 1.6μM |
| AuroraA | IC50: >10μM |
| AuroraB | IC50: >10μM |
| MEK | IC50: >10μM |
| In vitro (25°C) | DMSO | 80 mg/mL (177.57 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 5% DMSO+50% PEG 300+5% Tween+ddH2O | 4 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 22.2 mL | 110.99 mL | 221.98 mL |
| 0.5 mM | 4.44 mL | 22.2 mL | 44.4 mL |
| 1 mM | 2.22 mL | 11.1 mL | 22.2 mL |
| 5 mM | 0.44 mL | 2.22 mL | 4.44 mL |
*The above data is based on the productmolecular weight 450.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A10185 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 450.5 |
| Formula | C25H27FN4O3 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 288383-20-0 |
| Synonyms | Recentin |
| SMILES | CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5 |
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂，是一种酪氨酸激酶抑制剂，对于HUVEC增殖，PC-9细胞和酪氨酸激酶活…
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂，可选择性抑制血管内皮生长因子受体2（VEGFR2，也称为KDR），后者…
Motesanib (AMG706)
Motesanib(AMG706)是一种多激酶抑制剂，可选择性靶向VEGF受体，血小板衍生的生长因子受体（PDGFRs）和Kit受体…
Brivanib (BMS-540215)
Brivanib (BMS-540215)是一种VEGFR-2抑制剂，IC50为25 nM，Ki为26 nM。
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体（EGFR），HER2和HER4抑制剂，以及VEGF受体激酶。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂，IC50为17、40和69 nM c-KIT，VEGFR2，B-Raf。Regorafenib（BAY 73-4506）是一种…
Raf265 derivative
Raf265 derivative是Raf265的衍生物，Raf265是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，IC50为5至10μM。
Keywords:购买 Cediranib (AZD2171) | Cediranib (AZD2171) 供应商 | 订购 Cediranib (AZD2171) | Cediranib (AZD2171) 价格 | Cediranib (AZD2171) 生产商 | 订单 Cediranib (AZD2171) | Cediranib (AZD2171) 代理商 | 购买 288383-20-0| 288383-20-0 供应商 | 订购 288383-20-0 | 288383-20-0 价格 | 288383-20-0 生产商 | 订单 288383-20-0 | 288383-20-0 代理商|buy Cediranib (AZD2171) | Cediranib (AZD2171) Supplier | purchase Cediranib (AZD2171) | Cediranib (AZD2171) cost | Cediranib (AZD2171) manufacturer | order Cediranib (AZD2171) | Cediranib (AZD2171) distributor | buy 288383-20-0| 288383-20-0 Supplier | purchase 288383-20-0 | 288383-20-0 cost | 288383-20-0 manufacturer | order 288383-20-0 | 288383-20-0 distributor